Malign Hipertermi ve Anestezi Yönetimi
References
Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis 2015; 10: 93.
Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg. 2014 Feb;118(2):381-387. doi: 10.1213/ANE.0b013e3182937d8b. PMID: 23842196.
Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010 Feb 1;110(2):498-507. doi: 10.1213/ANE.0b013e3181c6b9b2. PMID: 20081135.
Riazi S, Kraeva N, Hopkins PM. Malignant hyperthermia in the post-genomics era: new perspectives on an old concept. Anesthesiology 2018; 128: 168-80.
Riazi S, Kraeva N, Hopkins PM. Updated guide for the management of malignant hyperthermia. Can J Anaesth. 2018 Jun;65(6):709-721. English. doi: 10.1007/s12630-018-1108-0. Epub 2018 Mar 29. PMID: 29600483.
Yeler H, Özan F, Özan Ü, Yeler D. Malignant Hipertermi. Cumhuriyet Üniversitesi Diş Hekimliği Fakülte Dergisi 2005;8:138-145.
Litman RS, Flood CD, Kaplan RF, Kim YL, Tobin JR. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry. Anesthesiology. 2008 Nov;109(5):825-9. doi: 10.1097/ALN.0b013e31818958e5.
Karadağ Erkoç, S., Özçelik, M., Bermede, A. O.,Demiralp, S. Erken Dönemde Dantrolen İle Tedavi Edilen Malign Hipertermi. Anestezi Dergisi 2016; 24 (3): 215 – 218.
Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg. 2014 Feb;118(2):381-387. doi: 10.1213/ANE.0b013e3182937d8b. PMID: 23842196.
Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg. 2010 Feb 1;110(2):498-507. doi: 10.1213/ANE.0b013e3181c6b9b2. PMID: 20081135.
Riazi S, Kraeva N, Hopkins PM. Malignant hyperthermia in the post-genomics era: new perspectives on an old concept. Anesthesiology 2018; 128: 168-80.
Riazi S, Kraeva N, Hopkins PM. Updated guide for the management of malignant hyperthermia. Can J Anaesth. 2018 Jun;65(6):709-721. English. doi: 10.1007/s12630-018-1108-0. Epub 2018 Mar 29. PMID: 29600483.
Yeler H, Özan F, Özan Ü, Yeler D. Malignant Hipertermi. Cumhuriyet Üniversitesi Diş Hekimliği Fakülte Dergisi 2005;8:138-145.
Litman RS, Flood CD, Kaplan RF, Kim YL, Tobin JR. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry. Anesthesiology. 2008 Nov;109(5):825-9. doi: 10.1097/ALN.0b013e31818958e5.
Karadağ Erkoç, S., Özçelik, M., Bermede, A. O.,Demiralp, S. Erken Dönemde Dantrolen İle Tedavi Edilen Malign Hipertermi. Anestezi Dergisi 2016; 24 (3): 215 – 218.
Pages
87-90
Published
April 20, 2024
Copyright (c) 2024 Academician Publishing Book Portal
License
LicenseHow to Cite
1.
Tümer M. Malign Hipertermi ve Anestezi Yönetimi. In: Özcengiz D, editor. Güncel Anesteziyoloji ve Ağrı Çalışmaları IX (Bahar) [Internet]. Türkiye: Academician Publishing Book DOI Portal; 2024 [cited 2026 Jul. 13]. pp. 87-90. Available from: https://omp35.books.akademisyen.net/index.php/akya/catalog/book/3070/chapter/13363
